
Segmed
Segmed is a YC Winter 2020 (W20) company. Based in Palo Alto, CA, USA; Remote. Team of 32.
About Segmed
Summary
Segmed supplies de-identified, regulatory-grade medical imaging datasets to pharmaceutical, medical device, and AI companies that need real-world clinical data for research and model development. Its Openda platform gives customers access to millions of multimodal studies drawn from a global network of healthcare providers, replacing the slow, fragmented work of sourcing and curating imaging data through individual hospital agreements. Buyers use the data to train diagnostic AI, support FDA and CE submissions, and run longitudinal disease research.
Business model
Subscription access to Segmed's imaging database, with dataset purchases for regulatory validation use cases.
Go-to-market
Life sciences firms, medical device makers, and AI developers are the primary buyers; they engage through a direct sales motion, booking calls with Segmed's team to scope fit-for-purpose dataset needs.
From the Y Combinator listing
Real-World Data for Health Innovation
Segmed provides at-scale access to novel clinical data globally, offering millions of diagnostic-grade medical images to accelerate innovation and mature the evidence needs of life sciences and technology industry. Our solutions allow you to access a Real World Data (RWD) network to facilitate rapid discovery and investigational capability of imaging data, development of early disease detection & prediction models, improved patient recruitment and reduced operating burden to access therapeutic data ecosystem.
Facts
- Healthcare / Healthcare -> Diagnostics
- Palo Alto, CA, USA; Remote
- 32
- Active
- Early
Founders (2)
- Jie Wu
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works